Jerónimo Martins (JMT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
18 Nov, 2025Executive summary
Q1 2025 sales rose 3.8% year-over-year to €8.4bn, with EBITDA up 3.8% to €528mn and net profit attributable to shareholders up 31.4% to €127mn, despite margin pressure from higher labor costs and low basket inflation.
Group EBITDA margin held steady at 6.3%, with net cash position (excluding capitalized leases) at €332mn at quarter-end.
71 new stores opened, including Biedronka's entry into Slovakia and Ara's expansion, with a strategic focus on price competitiveness and market share growth.
Cash flow was negative at €398mn, reflecting business seasonality and Easter timing.
Consumers remained cautious and highly promotion-driven, with management expecting continued volatility and cost pressure.
Financial highlights
Group sales rose 3.8% year-over-year, or 1.9% at constant exchange rates, reaching €8.4bn; gross profit margin improved to 20.8%.
EBITDA increased 3.8% to €528mn; EBIT rose 3.0% to €249mn; net profit attributable to shareholders up 31.4% to €127mn.
Like-for-like sales were -2.2%, impacted by calendar effects and tough comparables, especially at Biedronka.
Capex reached €267mn, mainly allocated to Biedronka and Ara.
Dividend of €0.59/share (€370.8mn total) approved, to be paid 15 May; €40mn allocated to the company foundation.
Outlook and guidance
2025 outlook reiterated: focus on price competitiveness, sustainable growth, and expansion amid high cost pressure and unpredictable consumer trends.
Management expects continued volatility, with margin and sales performance dependent on consumer behavior and competitive dynamics.
Capex program remains a top priority, with €1.1bn planned for 2025.
Biedronka to open 130–150 net new stores and renovate 250–275; expansion in Slovakia underway.
Ara plans over 150 new stores and integration of ~70 Colsubsidio stores; logistics investment ongoing.
Latest events from Jerónimo Martins
- Sales and EBITDA grew strongly, with robust expansion and disciplined execution across all markets.JMT
Q4 202519 Mar 2026 - Sales up 12.3% to €16.3bn, but net profit down 29% amid margin and cost pressures.JMT
H1 20243 Feb 2026 - Sales up 10.3% to €24.8B, but net profit and margins fell amid cost and deflation pressures.JMT
Q3 202417 Jan 2026 - Sales rose 7.6% to €35,991 million, driven by expansion and strong LFL growth across all banners.JMT
Q4 2025 TU13 Jan 2026 - Sales up 9.3% to €33.5bn, net profit down 20.8%, major 2025 investments planned.JMT
H2 202414 Dec 2025 - 6.7% sales growth, 10.3% EBITDA rise, and 6.6% profit gain, with robust expansion and margin discipline.JMT
Q2 20252 Nov 2025 - Sales up 7.1%, EBITDA up 10.9%, and net profit up 10% to €484M, with strong expansion.JMT
Q3 202530 Oct 2025